Europe’s drug regulatory agency has given Kizfizo a negative opinion for the second time, following one from November 2024.

The Scientific Advisory Group (SAG) has been called in to assist the EMA’s CHMP human medicines committee in its review of the drug, which is vying to become the first disease-modifying therapy ...

Biosimilar adalimumab is backed by robust science, assured by manufacturing ... Hefiya and Hyrimoz, the CHMP noted that biosimilars were “highly similar” to Humira, with “comparable quality ...

We recently compiled a list of the 11 Oversold Blue Chip Stocks to Buy According to Hedge Funds. In this article, we are ...

Otsuka Pharmaceutical Europe and Lundbeck have announced that the European Commission has approved Rxulti (brexpiprazole) for ...

Pfizer's Covid-19 vaccine is considered by healthcare authorities to be safe and effective, with data gathered from billions ...

Otsuka Pharmaceutical Europe Ltd. (Otsuka) and H. Lundbeck A/S (Lundbeck) today announced that the European Commission (EC) has approved Rxulti® (brexpiprazole) for the treatment of schizophrenia in ...

Full year 2024 total revenues increased by 21% to US$297.2 million and exceeded our guidance, driven by record RUCONEST® revenue and strong ...

DelveInsight's "VERZENIO Market Size, Forecast, and Market Insight Report" highlights the details around VERZENIO, which is a targeted treatment known as ...

Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters. March 4, 2025 • A study finds that Peto's Paradox, which states that larger ...

We look back on about 11 years of the Gaia spacecraft, now at the end of its mission to create the best map of the Milky Way. In this week’s news roundup, we cover activity from the black hole ...

Studying the Evolutionary History of Continent-Sized Regions in the Deep Mantle Feb. 28, 2025 — Scientists have revealed that two continent-size regions in Earth's deep mantle have distinctive ...